Aurobindo Pharma gets USFDA observations on Hyderabad unit

The company has received a 'Form 483' with 10 observations. However, none of the observations is repetitive and is more procedural in nature, the pharma company said.

from India Infoline News Service http://bit.ly/2IkRs35